A gold standard for anti-aging
With four different kinds to choose from, ZO Facials are designed to provide a comprehensive regimen that will address different skin concerns such as anti-ageing, brightening, oil control and redness control
GLP-1, GIP, and glucagon each regulate distinct but interconnected signaling networks associated with nutrient sensing, cellular metabolism, and endocrine communication
A recent study in Nature Medicine reported that GLP-1 receptor agonists are associated with lower risk of various health conditions, including coagulation disorders, heart conditions, infectious diseases and neurocognitive disorders like Alzheimers disease
Launching oral GLP-1s requires more than extending injectable playbooks
The treatment starts with a dose of 0.25 mg once weekly for four weeks, after which the dose is gradually increased until reaching a maintenance dose of 2.4 mg weekly